PMID- 29556248 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201001 IS - 1664-8021 (Print) IS - 1664-8021 (Electronic) IS - 1664-8021 (Linking) VI - 9 DP - 2018 TI - Growth of Triple Negative and Progesterone Positive Breast Cancer Causes Oxidative Stress and Down-Regulates Neuroprotective Transcription Factor NPAS4 and NPAS4-Regulated Genes in Hippocampal Tissues of TumorGraft Mice-an Aging Connection. PG - 58 LID - 10.3389/fgene.2018.00058 [doi] LID - 58 AB - While the refinement of existing and the development of new chemotherapeutic regimens has significantly improved cancer treatment outcomes and patient survival, chemotherapy still causes many persistent side effects. Central nervous system (CNS) toxicity is of particular concern, as cancer patients experience significant deficits in memory, learning, cognition, and decision-making. These chemotherapy-induced cognitive changes are termed chemo brain, and manifest in more than half of cancer survivors. Moreover, recent studies have emerged suggesting that neurocognitive deficits manifest prior to cancer diagnosis and treatment, and thus may be associated with tumor presence, a phenomenon recently termed "tumor brain." To dissect the molecular mechanisms of tumor brain, we used TumorGraft(TM) models, wherein part of a patient's tumor is grafted into immune-deficient mice. Here, we analyzed molecular changes in the hippocampal tissues of mice carrying triple negative (TNBC) or progesterone receptor positive (PR+BC) xenografts. TNBC growth led to increased oxidative damage, as detected by elevated levels of 4-hydroxy-2-nonenal, a product of lipid peroxidation. Furthermore, the growth of TNBC and PR+BC tumors altered global gene expression in the murine hippocampus and affected multiple pathways implicated in PI3K-Akt and MAPK signaling, as well as other pathways crucial for the proper functioning of hippocampal neurons. TNBC and PR+BC tumor growth also led to a significant decrease in the levels of neuronal transcription factor NPAS4, a regulator that governs the expression of brain-derived neurotrophic factor (BDNF), and several other key brain neurotrophic factors and pro-survival molecules. The decreased expression of ERK1/2, NPAS4, and BDNF are also seen in neurodegenerative conditions and aging, and may constitute an important tumor brain mechanism. FAU - Kovalchuk, Anna AU - Kovalchuk A AD - Department of Neuroscience, University of Lethbridge, Lethbridge, AB, Canada. AD - Leaders in Medicine Program, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. FAU - Ilnytskyy, Yaroslav AU - Ilnytskyy Y AD - Department of Biological Sciences, University of Lethbridge, Lethbridge, AB, Canada. FAU - Rodriguez-Juarez, Rocio AU - Rodriguez-Juarez R AD - Department of Biological Sciences, University of Lethbridge, Lethbridge, AB, Canada. FAU - Katz, Amanda AU - Katz A AD - Department of Oncology, Champions Oncology, Baltimore, MD, United States. FAU - Sidransky, David AU - Sidransky D AD - Department of Oncology, Champions Oncology, Baltimore, MD, United States. AD - Department of Otolaryngology and Oncology, Johns Hopkins University, Baltimore, MD, United States. FAU - Kolb, Bryan AU - Kolb B AD - Department of Neuroscience, University of Lethbridge, Lethbridge, AB, Canada. FAU - Kovalchuk, Olga AU - Kovalchuk O AD - Department of Biological Sciences, University of Lethbridge, Lethbridge, AB, Canada. LA - eng PT - Journal Article DEP - 20180305 PL - Switzerland TA - Front Genet JT - Frontiers in genetics JID - 101560621 PMC - PMC5845109 OTO - NOTNLM OT - animal models OT - brain ageing OT - gene expression OT - non-CNS cancer OT - tumor brain EDAT- 2018/03/21 06:00 MHDA- 2018/03/21 06:01 PMCR- 2018/03/05 CRDT- 2018/03/21 06:00 PHST- 2017/11/24 00:00 [received] PHST- 2018/02/08 00:00 [accepted] PHST- 2018/03/21 06:00 [entrez] PHST- 2018/03/21 06:00 [pubmed] PHST- 2018/03/21 06:01 [medline] PHST- 2018/03/05 00:00 [pmc-release] AID - 10.3389/fgene.2018.00058 [doi] PST - epublish SO - Front Genet. 2018 Mar 5;9:58. doi: 10.3389/fgene.2018.00058. eCollection 2018.